Author

E. Perouzel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Debin· 1 shared B. Hansen· 1 shared D. Kim· 1 shared E. K. Axelgaard· 1 shared F. Vernejoul· 1 shared H. Hager· 1 shared H. K. Cai· 1 shared J. G. Giehm Mikkelsen· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Debin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The defined TLR3 agonist, Nexavant, exhibits anti-cancer efficacy and potentiates anti-PD-1 antibody therapy by enhancing immune cell infiltration.

D. Kim, S.-H. Lee, Y.-H. Choi, S.-M. Kang, M.-G. L. Lee, S.-B. Hong, E. Perouzel, A. Debin

This paper evaluates Nexavant, a TLR3 agonist, showing enhanced anti-cancer effects and synergy with anti-PD-1 therapy through immune cell infiltration.

bioRxiv · Oct 25, 2023Immunology

STING activation counters glioblastoma by vascular alteration and immune surveillance

J. V. Joseph, M. S. Blaavand, H. K. Cai, F. Vernejoul, R. W. Knopper, T. B. Lindhardt, K. K. Skipper, E. K. Axelgaard, L. K. Reinert, J. G. Giehm Mikkelsen, P. Borghammer, S. E. Degn, E. Perouzel, H. Hager, B. Hansen, , M. K. Thomsen

This study shows that STING activation reduces glioblastoma progression and prolongs survival by altering tumor vasculature and enhancing immune surveillance.

bioRxiv · Sep 3, 2023Cancer Biology